Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;3(2):77-83.
doi: 10.4103/2229-516X.117051.

A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting

Affiliations

A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting

Kamalpreet Kaur et al. Int J Appl Basic Med Res. 2013 Jul.

Abstract

The day the wonder drugs, antibiotics, were available for cure to humans; dramatic rise of average life expectancy has been recorded compared to past. However, disease-causing microbes that have developed resistance to antibiotics are an increasing public health problem. Recently, superbug emergence was reported in some countries including India. One of the reasons quoted was misuse of antibiotics. Clinical signs and symptoms of infection often do not point towards the etiology. The dilemma occurs as diagnosis of sepsis is difficult because of nonspecificity of clinical signs and symptoms, and frequent overlapping of symptoms with other noninfectious causes of systemic inflammation. Key for improving survival rates lies in early diagnosis and treatment. Serum procalcitonin (PCT) levels measuring in sick patients during infection may be valuable in diagnosing the conditions, and its changing levels have some prognostic value too.

Keywords: Biomarkers; procalcitonin; resistance; sepsis; systemic inflammatory response syndrome.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Procalcitonin-based algorithm as a guide of antibiotic usage

Similar articles

Cited by

References

    1. Kristopher AM, Nikola AB. Procalcitonin: Clinical utility in diagnosing sepsis. Clin Lab News. 2009;37:76–8.
    1. Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–55. - PubMed
    1. Mahajan R, Gupta K. Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies. J Pharm Bioallied Sci. 2010;2:307–13. - PMC - PubMed
    1. Mondal SK, Nag DR, Banyopadhyay R, Chakraborty D, Sinha SK. Neonatal sepsis: Role of battery of immunohematological tests in rapid diagnosis. Int J Appl Basic Med Res. 2012 In Press. - PMC - PubMed
    1. Povoa P. C-reactive protein: A valuable marker of sepsis. Intensive Care Med. 2002;28:235–43. - PubMed